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1. INTRODUCTION 
Based on Health ministry reported cases of Human Immunodeficiency Virus (HIV) from 
2005 to December 2017 amounted to 280,623 people. The cumulative number of AIDS from 
1987 to December 2017 was 102,667 people.1,2 The highest number of cases of infection were 
DKI Jakarta with 51,981 people, followed by East Java with 39,633 people, Papua 29,083 
people, West Java 28,964 people and Central Java with 22,292 people.2,3 
Based on data from the Directorate General of Disease Prevention and Control, the 
Ministry of Health of the Republic of Indonesia in 2017 in East Nusa Tenggara Province the 
Human Immunodeficiency Virus (HIV) is a retrovirus originating from 
the retroviridae family of the genus lentivirus that infects and damages 
cells that have a molecule Cluster of Differentiation 4 (CD4), especially 
T lymphocytes that have receptors with high affinity for HIV. Total 
lymphocyte count / TLC has been proposed as an alternative guide to 
CD4 in limited health facilities. This study aims to determine the 
correlation between Total Lymphocyte Count (TLC) and CD4 in 
HIV/AIDS patients in the W.Z. Johannes Kupang hospital. The type of 
this research was observational analytic with a cross-sectional design. 
The study was conducted on 121 samples of patients who performed 
CD4 examination and Total Lymphocytic Count (TLC) in the laboratory 
of W.Z.Johannes Kupang Hospital. The Spearman correlation test 
shows a significance value of 0,000 with a Spearman correlation value 
of 0.799. Based on the results of this study it can be concluded that 
there is a significant correlation between Total Lymphocyte Count and 
CD4 and shows the direction of positive correlation with a very strong 
relationship, where the increase in the number of Total Lymphocyte 
Count is in line with the increase in CD4 counts. 
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number of HIV infections reported up to December 2017 was 3,464 people and AIDS cases 
were 1,965 people.2,4 
HIV is a retrovirus originating from the retroviridae family of the genus lentivirus which 
infects and damages cells that have Cluster of Differentiation 4 (CD4) molecules, especially T 
lymphocytes that have receptors with high affinity for HIV.5 This viral infection results in a 
continuous decline in the immune system.6,7 The main target of HIV infection is through CD4 
cells. Normal CD4 cell count ranges from 500 - 1600 cells / mm3 of blood. CD4 cell count is a 
way to assess the immunity status of people with HIV-AIDS (ODHA). CD4 examination 
completes a clinical examination to determine patients who need prophylactic IO and 
antiretroviral therapy.1 
Several studies have shown that to monitor the condition of HIV patients can use 
several parameters including delayed-type hypersensitivity responses, haemoglobin (Hb)8, 
total lymphocyte count (TLC), serum albumin levels, and body mass index.9,10,11 The gold 
standard for CD4 examination is to use a flow meter, but it requires expensive equipment, so 
it is difficult to obtain in areas with limited facilities.10,12,13 WHO's anti-retroviral therapy 
guidelines state that if CD4 count cannot be obtained, the total lymphocyte count (TLC) will be 
used as a replacement.14 
General Hospital Prof. DR. W. Z. Johannes Kupang has a special clinic for Counseling 
and Testing (Voluntary Counseling and Testing / VCT) as well as Care, Support and Treatment 
(Care, Support and Treatment / CST), namely the VCT CCT Sobat Clinic. A number of Patient 
visit at the VCT Sobat clinic at General Hospital W.Z.Johannes in 2018 were 9,244 people, 
with 229 HIV positive cases. The total cumulative ODHA who get ARV therapy in CST Sobat 
clinic until September 2018 was 627 people. Monitoring of CD4 count can be done at 
Laboratory of General Hospital Prof. DR. W. Z. Johannes Kupang, but the availability of 
reagents is very limited. Examination data shows that in 2017 Laboratory of General Hospital 
Prof. DR. W. Z. Johannes Kupang can only perform 70 CD4 examinations, whereas in 2018 
only 50 reagents are received. This amount is very lacking, considering that the CD4 
examination is not only used to determine the start of treatment in new patients but also is 
used to assess the success of ARV treatment. Decreased CD4 cell count results in reduced 
TLC as evidenced by Resindra et al., that TLC can be used as a replacement check for CD4 
cell count in monitoring HIV infection.15 The results of research conducted by Sanjaya's et al., 
also support the existence of a moderate correlation of TLC with CD4 cell count in all aspects 
of study.16 
There are differences in the results of the research found both conducted abroad and 
in Indonesia as well as the limited research on the relationship between TLC and CD4 in 
Indonesia, especially in East Nusa Tenggara. Akinola et al., states that there is no strong 
correlation between TLC and CD4 (female: r = 0.473; male r = 0.384).17 Irianto et al., also 
states There is a weak correlation between the number of lymphocytes with the number of 
CD4 cells, so the calculation of the number of lymphocytes cannot be used as an alternative 
in monitoring therapy.18 The purpose of this study was to find the correlation between Total 
Lymphocyte Count (TLC) with CD4 in HIV/AIDS patients at General Hospital Prof. DR. W. Z. 
Johannes Kupang. 
 
2. MATERIALS AND METHOD 
This research was conducted at the Clinical Pathology Installation General Hospital W. 
Z. Johannes Kupang in April 2019. The sample study was data on HIV/AIDS patients who 
performed routine blood/total lymphocyte count and CD4 counts and obtained 121 patients. 
Data was collected and analyzed using SPSS for Windows software. 
This study was an analytic observational study with a cross-sectional design. The 
sample of this study were patients diagnosed with HIV from the VCT / CST Clinic of General 
Hospital Prof. DR. W. Z. Johannes Kupang, who conducted routine CD4 and blood/lymphocyte 
examinations in the laboratory of the General Hospital Prof. DR. W. Z. Johannes Kupang. This 
research has received ethical approval through the ethics committee of the Faculty of 
Medicine, Gadjah Mada University with number: KE / 223 / EC / 2016.  
The criteria of the sample were patients diagnosed with HIV from the VCT / CST Clinic 
of General hospital Prof. Dr. W.Z. Johannes Kupang, which conducts routine CD4 and 
blood/lymphocyte examinations in the laboratory. We used secondary data in the form of 
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patient medical records recorded General Hospital Prof. DR. W. Z. Johannes Kupang.  The 
variables studied in this study were CD4 count that was calculated using the PIMA Analyzer 
with cell / µl unit and Total Lymphocyte Count (TLC) calculated by the Automated Hematology 
Analyzer Sismex XN 550 with cell / µl unit. Pearson correlation test was used to find the 
correlation between Total Lymphocyte Count and CD4 count if the data were normally 
distributed. If the data are not normally distributed, then the Spearman correlation test would 
be used. 
 
3. RESULTS AND DISCUSSION 
This research was conducted at the Clinical Pathology Installation General hospital 
Prof. DR. W. Z. Johannes Kupang in April 2019. The sample study was data on HIV/AIDS 
patients who performed routine blood/total lymphocyte count and CD4 counts and obtained 
121 patients. Data was collected and analyzed using statistical software. 
 
Table 1. Distribution of Samples based on CD4 Count and Total Lymphocyte Count 
Characteristics 
Man Female 
Total Percentage(%) Total 
Percentage   
(%) 
CD4 Count     
 > 500 5 6.4 7 16.3 
 350 – 499 5 6.4 6 13.9 
 200 – 349 11 14.1 11 25.6 
 < 200 57 73.1 19 44.2 
 Total 78 100 43 100 
Lymphocyte Count     
 < 1000 33 42.3 16 37.2 
 > 1000 45 57.7 27 62.8 
 Total 78 100 43 100 
Based on table 1, the percentage of total lymphocyte count in this study is more than 1000 
cells / µl, while the percentage of CD4 is less than 200 cells / µl. After grouping based on CD4 
count, in the CD4 group that is more than 350 cells / µl, and the total lymphocyte count still 
exceeds 1000 cells / µl. Meanwhile, in the CD4 group that is less than 200 cells / µl, there is 
95.9% of the study sample with a total lymphocyte count that is less than 1000 cells /µl. This 
is probably due to the fact that no definitive information was obtained from the study samples 
regarding the patient's infection phase, whether people with HIV were in the acute infection 
phase or were still in the latent infection phase where most lymphocyte counts were still within 
normal limits, but there had been a decline in CD4 counts.12 These results also provide a 
general picture that the decrease in total lymphocyte count mostly occurs only in patients with 
CD4 count that is less than 200 cells / µl. 
 
Table 2. Spearman Correlation Test Results 
Variable N Correlation Coefficient Sig. 
Total  Lymphocyte Count 121 
0.799*** 0.000 CD4 121 
 
The results of statistical analysis with the Spearman correlation test on the entire study 
samples showed that there was a significant correlation between Total Lymphocyte Count and 
CD4 (p = 0.000). They showed the direction of a positive correlation with a very strong 
relationship (r = 0.799). 
The existence of a positive correlation between Total Lymphocyte Count (TLC) with 
CD4 in HIV/AIDS patients is based on the theory that a decrease in Total Lymphocyte Count 
(TLC) can cause a decrease in CD4 count. CD4 is a part of lymphocytes. Lymphocytes consist 
of two subtypes, namely T lymphocytes and B lymphocytes. B lymphocytes will be converted 
into plasmocytes to form antibodies in the humoral defence system. T lymphocytes which are 
primary cells of the cellular defence system that can be divided into helper T cells (CD4) and 
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suppressor T cells (CD8). CD4 cells are the largest part of T lymphocytes, which is 34-
67%.3,19,20 
In HIV infection, selective reduction in CD4 cells is found due to the direct effects of the 
virus or the body's immune response. This selective reduction is due to the tropism of the virus 
to infect CD4 cells. As part of lymphocytes, reduction of CD4 cells count will also decrease 
Total Lymphocyte Count.19 Coinfection with other diseases such as Hepatitis B, Hepatitis C, 
and tuberculosis will further reduce the patient's immune system so that it will cause a CD4 
cell count to decrease.20,21 This situation is also called an opportunistic infection.22,21 
The results of this study did not differ significantly from research conducted by Sanjaya, 
et al., on 350 subjects at Hospital of Dr. Hasan Sadikin Bandung which divided by WHO 
clinical-stage, and then the data were analyzed using Pearson correlation analysis and Fisher's 
r-to-z transformation. Results of the study obtained a good and statistically significant 
correlation between the number of CD4 lymphocytes and the number of lymphocytes at all 
stages of HIV infection. 
The results of research conducted by the Sanjaya et al17, have a slight difference which 
states that in every clinical-stage, they have moderate correlation, whereas in this study the 
statistical test results show a strong correlation. This is because, in this study, researchers only 
tested in general, and only divided the characteristics of the research based on sex. 
A positive correlation between lymphocyte count and CD4 lymphocyte count is also 
shown in the study of Swati AF, et al.2 The results of this study indicated a decrease in CD4 
lymphocytes count followed by a decrease in the lymphocytes count. The study of Swati AF, 
et al. has a difference with this study in which retrospective data collection is performed on the 
medical records of children who have HIV who are hospitalized and subjects are controlled by 
several variables such as sex, age, (Body Mass Index) BMI, haemoglobin level, leukocytes 
count, and platelets.2 
The results of this study differ from those of Akinola et al., In which the study states that 
there is no strong correlation between TLC and CD4 (women: r = 0.473; men: r = 0.384).17 The 
difference from this study lies in the study sample, where Akinola et al. take study samples 
from patients with HIV-1 antibodies but have not yet started the ARV therapy. Others study 
states the same thing that there is a strong correlation between CD4 and TLC, but that 
correlation weakens when patients were divided into groups according to their CD4 count.6,13 
The results of strong correlations in this study were also possible because this study 
only analyzed the correlation of total lymphocyte count and CD4 count in general, without 
dividing in detail from age group, clinical-stage, duration of ARV therapy or other factors 
affecting total lymphocyte count and CD4 count. The limitations of this study are expected to 
be a consideration for understanding the results of this study. 
 
4. CONCLUSION 
There was a significant correlation between Total Lymphocyte Count and CD4. The 
results of this study also showed the direction of positive correlation with a very strong 
relationship, where the increase in the Total Lymphocyte Count was in line with the increase 
in CD4 count. 
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